Innovative malaria prodrug targets liver, enhances efficacy while reducing toxicity, preclinical studies show

Tafenoquine, a prodrug that could fulfill the criteria for a mass eradication campaign.

Amgen sees highest filings and grants during July in Q3 2023

Share this article Amgen has been focused on protecting inventions in European Patent Office (E/P) with 91 publications in Q3 2023 The European Patent Office

November 24, 2023

Biden administration says IRA negotiations will result in $6B in 2026 Medicare savings

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

August 16, 2024

PTC reports Phase 2 ALS fail, sells priority review voucher for $150M

PTC Therapeutics is staying busy ahead of the Thanksgiving holiday. On Tuesday afternoon, the company announced that a Phase 2 trial evaluating its experimental ALS

November 28, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.